Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance with Dyslipidemia

Diabetes Care

Volumn 27, Issue 4, 2004, Pages 978-983

  Liao, Youlian ^a   Kwon, Soonho ^b   Shaughnessy, Sara ^b   Wallace, Penny ^c   Hutto, Amy ^b   Jenkins, Alicia J ^d   Klein, Richard L ^b,e   Garvey, W Timothy ^c,f  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^f BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRACTICE GUIDELINE; RELIABILITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PRACTICE GUIDELINES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 1842485893     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.4.978     Document Type: Article

References (25)

1. Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473-486, 1995
2. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-174, 1991
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol (Adults Treatment Panel III). JAMA 285:2486-2497, 2001
4. Stern MP: The insulin resistance syndrome. In International Textbook of Diabetes Mellitus. 2nd ed. Alberti KGMM, Zimmet P, Defronzo RA, Eds. Chichester, U.K., Wiley, 1997, p. 255-283
5. Donahue RP, Bean JA, Donahue RD, Goldberg RB, Prineas RJ: Does insulin resistance unite the separate components of the insulin resistance syndrome: evidence from the Miami Community Health Study. Arterioscler Thromb Vasc Biol 17: 2413-2417, 1997
6. Grundy SM: Hypertriglyceridemia, insulin resistance, and the Metabolic Syndrome. Am J Cardiol 83:25F-29F, 1999
7. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyorala K, Salonen JT, Karhapaa P: Asymptomatic atherosclerosis and insulin resistance. Artherioscler Thromb 11:1068-1076, 1991
8. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
9. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG: The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34:222-234, 1985
10. Otvos JD: Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab 48:171-180, 2002
11. Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH: Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 51: 1949-1956, 2002
12. Blake GJ, Otvos JD, Rifai N, Ridker PM: Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 106:1930-1937, 2002
13. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y: Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52:453-462, 2003
14. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curves. Radiology 143:29-36, 1982
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 25 (Suppl. 1):S5-S20, 2002
16. Ford ES, Giles WH, Dietz WH: Prevalence of the Metabolic Syndrome among U.S. adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356-359, 2002
17. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518-524, 1988
18. Rosenson RS, Freedman DS, Otvos JD: Relations of lipoprotein subclass levels and LDL size to progression of coronary artery disease in the PLAC I trial. Am J Cardiol 90:89-94, 2002
19. St. Pierre AC, Ruel IL, Cantin B, Dagenais GR, Bernard PM, Despres JP, Lamarche B: Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104:2295-2299, 2001
20. Festa A, D'Agostino R, Mykkanen L, Tracy R, Hales CN, Howard BV, Haffner SM: LDL particle size in relation to insulin, proinsulin, and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes Care 22:1688-1693, 1999
21. Friedlander Y, Kidron M, Caslake M, Lamb T, McConnell M, Bar-On H: Low density lipoprotein particle size and risk factors of insulin resistance syndrome. Atherosclerosis 148:141-149, 2000
22. Haffner SM, D'Agostino R Jr, Saad MF, Rewers M, Mykkanen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, Bergman RN: Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes 45:742-748, 1996
23. Miller M, Seidler A, Moalemi A, Pearson TA: Normal triglyceride levels and coronary artery events: the Baltimore Coronary Observational Long-Term Study. J Am Coll Cardiol 31:1252-1257, 1998
24. Havel RJ: Plasma triglycerides and the clinician: time for re-assessment. J Am Coll Cardiol 31:1258-1259, 1998
25. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988